ANVS · CIK 0001477845 · FY2025 live · 2025-12-31
Annovis Bio, Inc.
View as
Model
Classic Z
FY2025
−13.34
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−13.34
Z″ −31.73
Score −13.34 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
−0.171.2 × = −0.21X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−7.771.4 × = −10.87X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−1.413.3 × = −4.65X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
3.980.6 × = 2.39X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.
Meridian Rank
4.91
0–100 · Classic Z family
Book standing
6
Year change
—
Market PD
—
O-score
2
Events on this name
Same published rows as Today.
No published events on this print.
Overview
rule-v1
Annovis Bio, Inc. is on classic Z at −13.34 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 12th percentile in Healthcare.
- CVDistressCapsoVision, Inc−13.46
- TNONDistressTenon Medical, Inc.−13.21
- LUCDDistressLucid Diagnostics Inc.−13.06
- ICCMDistressIceCure Medical Ltd.−13.69
- SKYEDistressSkye Bioscience, Inc.−13.77
- NXTCDistressNextCure, Inc.−13.78
- BMEADistressBiomea Fusion, Inc.−13.87
- TLSIDistressTriSalus Life Sciences, Inc.−13.93
Filing line items
Current assets
$0
Total assets
$21M
Current liabilities
$4M
Total liabilities
$4M
Working capital
−$4M
Retained earnings
−$164M
EBIT
−$30M
Total sales
$0
Book equity
$17M
Accession 0001104659-26-027751. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.